Navigation Links
eResearchTechnology Announces Resignation of its CFO
Date:5/20/2008

llenges and rewards of working with a clinical stage company and I am fully committed to assisting eRT's senior management and Board of Directors to ensure a smooth transition."

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2008 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
2. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
3. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
4. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
5. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
6. eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008
7. eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference on May 7th 2008
8. eResearchTechnology Reports First Quarter 2008 Results
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2008)...e-FirstCall/ -- PURE Bioscience (Nasdaq:,PURE), cr...rogen citrate,(SDC), today reported revenues for t...which increased more than 340% compared with $336,... a loss from operations before taxes,of $(6,540,30...$(4,654,900), or $(0.19) per share, in the prior y...
(Date:10/15/2008)...FirstCall/ - GeneNews Limited (TSX: GEN),a compan...s for the early,detection of diseases and personal...s appointed Patrick Terry as its lead strategic ad...y(TM), the world,s fist blood-based,test to determ... Mr. Terry,is one of the co-founders of Genomic He...
(Date:10/14/2008)...gma-Aldrich,s leading MISSION(TM) shRNA ... /- Sigma-Aldrich (Nasdaq: SIAL ), a...Ai Consortium (TRC),proudly welcomes the Memorial...ship Program ( http://sigma-aldrich.com/rpp ). The...h access to cutting-edge products in,Sigma-Aldrich...
(Date:10/14/2008)...ss Results to Be Held at 9:00 A.M. -, EXTON, Pa.,...rporated,s,(Nasdaq: VPHM ) third quarter financia...Wednesday, October 29, 2008 before the open of the... conference call and live audio webcast at 9:00,a....ence call, ViroPharma,management will discuss the ...
Breaking Biology Technology:PURE Bioscience Reports Fourth Quarter and Year End Results 2PURE Bioscience Reports Fourth Quarter and Year End Results 3PURE Bioscience Reports Fourth Quarter and Year End Results 4PURE Bioscience Reports Fourth Quarter and Year End Results 5PURE Bioscience Reports Fourth Quarter and Year End Results 6PURE Bioscience Reports Fourth Quarter and Year End Results 7GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM) 2Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program 2Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program 3ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008 2
..., , , , , , , ...ze, , , 1691112, ... , , , , Package Inserts/Product ,... , version - 42 K , English...S Material Safety , Data Sheets, ,...
..., , , , , , , ...ze, , , 1691104, ..., , , , Package , Inserts...sh , version - 24 K , Germa... US Material Safety , Data Sheets , ...
..., , , , , , Here are ..., regarding misincorporation or low fideli..., , , , ,... , , <a , ...too high , , , , ...
..., , , , , , from rat ... , , , , Catal... , 3335399, 2000 units,... 10000 units (5 vials of 2000 U, , ...ge Inserts/Product , Instructions, ...
Other Biology Technology:Trouble-shooting: Misincorporation or low fidelity 2Trouble-shooting: Misincorporation or low fidelity 3
(Date:10/15/2008)...ctober 28, 2008) -- A study(1) published in the No...al Sciences, which is published by Oxford Journal...s the kidney toxicity of melamine and cyanuric aci...the toxicity of the compounds that contaminated pe...ints to a possible link between the pet food conta...
(Date:10/15/2008)...r that helps optimize brain formation and function...fering with schizophrenia are headed toward relaps...-half years, they are regularly measuring levels o...he blood of patients with schizophrenia to see if ...ator that patients are headed for trouble, say Med...
(Date:10/15/2008)... Supercomputer Center (SDSC) at the University of ...unique facility called the Triton Resource, a high...that will accelerate innovation, collaboration, an...ch cyberinfrastructure at SDSC. , SDSC is leadin...primarily for UC and UC San Diego researchers. Sp...
(Date:10/15/2008)...5 October 2008 Fifty-nine leading life scientists...nised by the European Molecular Biology Organizati... Fifty-one of the researchers, distinguished as EM...ries, while eight equally respected scientists com...ate Members, bringing the current membership total...
Breaking Biology News(10 mins):Brain-nourishing molecule may predict schizophrenia relapse 2Brain-nourishing molecule may predict schizophrenia relapse 3San Diego Supercomputer Center and UCSD announce 'Triton Resource' 2San Diego Supercomputer Center and UCSD announce 'Triton Resource' 3San Diego Supercomputer Center and UCSD announce 'Triton Resource' 4EMBO honors 59 leading life scientists 2IMTEC Introduces New Vision Software 20336 1IMTEC Introduces New Vision Software 20336 2Also in the May 27 JNCI 20333 1Also in the May 27 JNCI 20333 2Also in the May 27 JNCI 20333 3Also in the May 27 JNCI 20333 4Erich Jarvis named Howard Hughes Investigator 3436 1Erich Jarvis named Howard Hughes Investigator 3436 2Erich Jarvis named Howard Hughes Investigator 3436 3Paclitaxel Plus Chemo Improves Outcomes in Early Breast Cancer 20331 1Paclitaxel Plus Chemo Improves Outcomes in Early Breast Cancer 20331 2
...r all its promise, the prospect of using nanoparti...cts has raised concerns about possible harmful eff... University of Michigan are addressing those conce...icles damage cell membranes---enough to cause cell...revented. , "If you,re inventing these sorts of ma...
...ees in the world¹s most productive forests -- fore... tend to die young, according to a U.S. Geological...f the journal Ecology Letters. This discovery coul... to ongoing and future environmental changes. , "O...the world¹s most productive forests may be those l...
...ltiple sclerosis (MS) can be an unpredictable dise...acks healthy nerve cells and disrupts normal nerve...mptoms—including tingling, paralysis, pain, fatigu...y or in combination, sporadically or persistently....flare-ups are common in the majority of patients. ...
...number of articles explore the use of positron emi...onsurgical techniques that open the door to unders...issue of the Society of Nuclear Medicine,s Journal...nimal imaging "is the ability to carry out many st..." said SNM member Michael J. Welch, Ph.D., co-auth...
Other Biology News:Probing the promise and perils of nanoparticles 2Live fast, die young true for forests too 2Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 4
Rad51B
Goat polyclonal to Dysadherin ( Abpromise for all tested applications). entrezGeneID: 53827
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies.
Biology Products: